XBiotech
XBIT
41 hedge funds and large institutions have $9.39M invested in XBiotech in 2022 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 7 increasing their positions, 19 reducing their positions, and 5 closing their positions.
0.99% less ownership
Funds ownership: 10.05% → 9.06% (-0.99%)
9% less funds holding
Funds holding: 45 → 41 (-4)
15% less capital invested
Capital invested by funds: $11.1M → $9.39M (-$1.69M)
63% less repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 19
80% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 5
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Man Group
London,
United Kingdom
|
+$108K |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$40K |
| 3 |
Bank of America
Charlotte,
North Carolina
|
+$38.8K |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$11.4K |
| 5 |
BlackRock
New York
|
+$7.73K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$292K |
| 2 |
Renaissance Technologies
New York
|
-$184K |
| 3 |
D.E. Shaw & Co
New York
|
-$113K |
| 4 |
HF
HRT Financial
New York
|
-$94.5K |
| 5 |
RC
RBF Capital
San Francisco,
California
|
-$84K |
XBIT Hedge Fund Activity: Q4 2022 in Review
41 of the 6,222 institutional investors tracked by Wall St. Rank reported a position in XBiotech (XBIT) for Q4 2022, worth a combined $9.39M — down 15% from $11.1M a quarter earlier.
Sellers outnumbered buyers: 5 funds closed out of XBIT and 1 opened new positions — a net loss of 4 holders — while 19 trimmed existing stakes and 7 added.
The largest buyer was Man Group, adding an estimated $108K. The largest seller was Millennium Management, cutting an estimated $292K.
- 41 institutional investors held XBiotech (XBIT) as of Q4 2022, down from 45 in Q3 2022.
- Funds reported $9.39M of XBiotech stock for Q4 2022, down 15% quarter-over-quarter.
- 1 fund opened new XBiotech positions in Q4 2022 and 5 closed out, a net change of -4 holders.
- The largest XBiotech buyer in Q4 2022 was Man Group, an estimated $108K added.
- The largest XBiotech seller in Q4 2022 was Millennium Management, an estimated $292K sold.
Based on aggregated 13F filings for Q4 2022.